Nano-HEALTH was a joint research project funded by the Austrian “Nano-Initiative”, a funding initiative designed to support the development of nanoscience and nanotechnology in Austria Project
Duration: March 2005 - February 2012 17
Project partners: universities, non-university research institutes, industry
Project volume: € 8.039.693
The main focus of Nano-Health was to use Nanotechnologies in medicine to enhance the quality of life of chronically ill patients suffering from diseases such as diabetes, cancer, and atherosclerosis.
In the ageing population of European society, there are high expectations for better quality of life, for which an important factor is improved, more efficient and affordable health care. Society is confronted with severe illnesses such as cardiovascular problems, diabetes, cancer, and inflammatory and infectious diseases. Focussed on these medical problems, nanotechnology offers impressive solutions. The use of NPs for early diagnosis, imaging and ‘smart’ drug delivery systems (“Nanocargo”) ensures better and personalized health care. The nanoHealth project aimed to develop new generations of NPs for diagnosis, imaging and drug delivery.